한국어

Longevity

Ergothioneine — timing, dose & interactions

Sulfur-containing antioxidant made by fungi and some bacteria — mushrooms are the richest food source. Higher blood levels were linked to lower cardiovascular and overall mortality in a Swedish cohort (observational). A small one-year pilot trial in mild cognitive impairment found it safe, with better scores on a learning test.

Also known as: L-ergothioneine, EGT

Timing

When to take it

Any time of day, with or without food. The body absorbs it avidly and holds on to it, so levels build up over weeks.

Interactions

Ergothioneine with other supplements

No documented supplement interactions in our dataset.

Safety

Medications & health conditions

CautionCancer treatment

Antioxidants may interfere with cancer treatment. Some chemotherapy and radiation work partly through oxidative damage; high-dose antioxidants could reduce their effect. Discuss every supplement with your oncology team.

Mechanism-based
CautionPregnant or breastfeeding

Ergothioneine supplements: no safety data in pregnancy. Ergothioneine supplements has not been studied for safety in pregnancy or breastfeeding. Avoid unless your clinician recommends it.

Mechanism-based

Buying guide

What to look for on the label

  • Ergothioneine

    • Pure L-ergothioneine
    • Mushrooms such as oyster, king oyster and shiitake are rich food sources

FAQ

Common questions

When is the best time to take Ergothioneine?

Breakfast. Any time of day, with or without food. The body absorbs it avidly and holds on to it, so levels build up over weeks.

Should Ergothioneine be taken with food?

It can be taken with or without food. Any time of day, with or without food. The body absorbs it avidly and holds on to it, so levels build up over weeks.

Sources

References

  1. 01Cheah IK et al. Administration of pure ergothioneine to healthy human subjects: uptake, metabolism, and effects on biomarkers of oxidative damage and inflammation. Antioxid Redox Signal 2017.
  2. 02Smith E et al. Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease. Heart 2020.
  3. 03Yau YF et al. Investigating the efficacy of ergothioneine to delay cognitive decline in mild cognitively impaired subjects: a pilot study. J Alzheimers Dis 2024.
Last reviewed Sourced from NIH fact sheets and peer-reviewed studies.How we make this contentReport an error